Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 151

Similar articles for PubMed (Select 23375927)

1.

Long-term follow-up of a pediatric cohort with short QT syndrome.

Villafañe J, Atallah J, Gollob MH, Maury P, Wolpert C, Gebauer R, Watanabe H, Horie M, Anttonen O, Kannankeril P, Faulknier B, Bleiz J, Makiyama T, Shimizu W, Hamilton RM, Young ML.

J Am Coll Cardiol. 2013 Mar 19;61(11):1183-91. doi: 10.1016/j.jacc.2012.12.025. Epub 2013 Jan 30.

2.

Long-term follow-up of patients with short QT syndrome.

Giustetto C, Schimpf R, Mazzanti A, Scrocco C, Maury P, Anttonen O, Probst V, Blanc JJ, Sbragia P, Dalmasso P, Borggrefe M, Gaita F.

J Am Coll Cardiol. 2011 Aug 2;58(6):587-95. doi: 10.1016/j.jacc.2011.03.038.

3.

Short QT syndrome: clinical findings and diagnostic-therapeutic implications.

Giustetto C, Di Monte F, Wolpert C, Borggrefe M, Schimpf R, Sbragia P, Leone G, Maury P, Anttonen O, Haissaguerre M, Gaita F.

Eur Heart J. 2006 Oct;27(20):2440-7. Epub 2006 Aug 22.

4.

High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator.

Korte T, Köditz H, Niehaus M, Paul T, Tebbenjohanns J.

Pacing Clin Electrophysiol. 2004 Jul;27(7):924-32.

PMID:
15271011
5.

Implantable cardioverter defibrillator therapy for prevention of sudden cardiac death in children in the Netherlands.

Heersche JH, Blom NA, van de Heuvel F, Blank C, Reimer AG, Clur SA, Witsenburg M, ten Harkel AD.

Pacing Clin Electrophysiol. 2010 Feb;33(2):179-85. doi: 10.1111/j.1540-8159.2009.02603.x. Epub 2009 Dec 15.

PMID:
20025697
6.
7.

Microvolt T-wave alternans in short QT syndrome.

Maury P, Extramiana F, Giustetto C, Cardin C, Rollin A, Duparc A, Mondoly P, Denjoy I, Delay M, Messali A, Leenhardt A, Marangoni D.

Pacing Clin Electrophysiol. 2012 Dec;35(12):1413-9. doi: 10.1111/j.1540-8159.2012.03491.x. Epub 2012 Aug 16.

PMID:
22897428
8.

Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia.

Sy RW, Gollob MH, Klein GJ, Yee R, Skanes AC, Gula LJ, Leong-Sit P, Gow RM, Green MS, Birnie DH, Krahn AD.

Heart Rhythm. 2011 Jun;8(6):864-71. doi: 10.1016/j.hrthm.2011.01.048. Epub 2011 Feb 9.

PMID:
21315846
9.

Outcome after implantation of cardioverter defibrillator [corrected] in patients with Brugada syndrome: a multicenter Israeli study (ISRABRU).

Rosso R, Glick A, Glikson M, Wagshal A, Swissa M, Rosenhek S, Shetboun I, Khalamizer V, Fuchs T, Boulos M, Geist M, Strasberg B, Ilan M, Belhassen B; Israeli Working Group on Cardiac Pacing and Electrophysiology.

Isr Med Assoc J. 2008 Jun;10(6):435-9. Erratum in: Isr Med Assoc J. 2008 Jul;10(7):549.

10.

Supraventricular arrhythmias in children and young adults with implantable cardioverter defibrillators.

Love BA, Barrett KS, Alexander ME, Bevilacqua LM, Epstein MR, Triedman JK, Walsh EP, Berul CI.

J Cardiovasc Electrophysiol. 2001 Oct;12(10):1097-101.

PMID:
11699514
11.

Implantable cardioverter-defibrillator therapy in Brugada syndrome: a 20-year single-center experience.

Conte G, Sieira J, Ciconte G, de Asmundis C, Chierchia GB, Baltogiannis G, Di Giovanni G, La Meir M, Wellens F, Czapla J, Wauters K, Levinstein M, Saitoh Y, Irfan G, Julià J, Pappaert G, Brugada P.

J Am Coll Cardiol. 2015 Mar 10;65(9):879-88. doi: 10.1016/j.jacc.2014.12.031.

PMID:
25744005
12.
13.

Implantable cardioverter defibrillator therapy in paediatric practice: a single-centre UK experience with focus on subcutaneous defibrillation.

Griksaitis MJ, Rosengarten JA, Gnanapragasam JP, Haw MP, Morgan JM.

Europace. 2013 Apr;15(4):523-30. doi: 10.1093/europace/eus388. Epub 2013 Jan 20.

14.

Importance of ventricular tachycardia storms not terminated by implantable cardioverter defibrillators shocks in patients with CASQ2 associated catecholaminergic polymorphic ventricular tachycardia.

Marai I, Khoury A, Suleiman M, Gepstein L, Blich M, Lorber A, Boulos M.

Am J Cardiol. 2012 Jul 1;110(1):72-6. doi: 10.1016/j.amjcard.2012.02.049. Epub 2012 Apr 3.

PMID:
22481011
15.

The use of implantable cardioverter-defibrillators in pediatric patients awaiting heart transplantation.

Dubin AM, Berul CI, Bevilacqua LM, Collins KK, Etheridge SP, Fenrich AL, Friedman RA, Hamilton RM, Schaffer MS, Shah M, Silka MJ, Van Hare GF, Kertesz NJ.

J Card Fail. 2003 Oct;9(5):375-9.

PMID:
14583898
16.

Congenital long QT 3 in the pediatric population.

Blaufox AD, Tristani-Firouzi M, Seslar S, Sanatani S, Trivedi B, Fischbach P, Paul T, Young ML, Tisma-Dupanovic S, Silva J, Cuneo B, Fournier A, Singh H, Tanel RE, Etheridge SP.

Am J Cardiol. 2012 May 15;109(10):1459-65. doi: 10.1016/j.amjcard.2012.01.361. Epub 2012 Feb 21.

PMID:
22360817
17.

Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy.

Lin G, Nishimura RA, Gersh BJ, Phil D, Ommen SR, Ackerman MJ, Brady PA.

Heart. 2009 May;95(9):709-14. doi: 10.1136/hrt.2008.150656. Epub 2009 Mar 11.

PMID:
19282314
18.

Implantable cardioverter defibrillator therapy in adults with congenital heart disease: who is at risk of shocks?

Koyak Z, de Groot JR, Van Gelder IC, Bouma BJ, van Dessel PF, Budts W, van Erven L, van Dijk AP, Wilde AA, Pieper PG, Sieswerda GT, Mulder BJ.

Circ Arrhythm Electrophysiol. 2012 Feb;5(1):101-10. doi: 10.1161/CIRCEP.111.966754. Epub 2011 Nov 17.

19.

Implantable cardioverter defibrillator implantation in children in The Netherlands.

Ten Harkel AD, Blom NA, Reimer AG, Tukkie R, Sreeram N, Bink-Boelkens MT.

Eur J Pediatr. 2005 Jul;164(7):436-41. Epub 2005 Apr 21.

PMID:
15843980
20.

Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients.

Berul CI, Van Hare GF, Kertesz NJ, Dubin AM, Cecchin F, Collins KK, Cannon BC, Alexander ME, Triedman JK, Walsh EP, Friedman RA.

J Am Coll Cardiol. 2008 Apr 29;51(17):1685-91. doi: 10.1016/j.jacc.2008.01.033.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk